CliffBio
small molecule

MEGESTROL ACETATE

MEGESTROL ACETATE

Loss of exclusivity—loss of exclusivity
CompanyNovitium Pharma →See this company's full patent-cliff portfolio

Drug detail

Brand nameMEGESTROL ACETATE
Active ingredientMEGESTROL ACETATE
Strength40MG/ML
Dosage formSUSPENSION
RouteORAL
ModalitySmall molecule
FDA approvalFebruary 2006
Marketing statusRX

More from Novitium Pharma

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.